Apostolos Tsiachristas

Contact information

Email	apostolos.tsiachristas@dph.ox.ac.uk
Tel	+44 (0)1865 289470

My connections

Green Templeton College College

Apostolos Tsiachristas

PhD

Senior Researcher

Senior Researcher (part-time) at Erasmus University Rotterdam

Economic evaluation of complex health interventions

Apostolos joined HERC as a senior researcher in January 2015. His current work includes the economic evaluation of integrated care models in diabetes, dementia and other chronic conditions (Oxford CLAHRC), hospital-at-home services in geriatric care (CGA trial), strategies to increase cervical screening uptake (STRATEGIC trial), and process changes in breast cancer screening (CO-OPS trial). He is also principal investigator in a Diabetes UK funded study that translates variation in the quality of diabetes care among general practices in England to lifetime health outcomes and costs.

Prior to his current positon, Apostolos worked at the Institute for Medical Technology Assessment, Erasmus University Rotterdam. There, he was involved in observational (ZonMw-Disease management project) and cluster-RCT (RECODE trial) studies, in which he undertook the economic evaluation of several disease management programs in many different disease areas. He also investigated the cost-effectiveness of new professionals and new professional roles in integrated care in a FP7 European project (MUNROS project). Apostolos also worked as consultant at APE, a public economics consultancy located in The Hague.

Apostolos has been teaching health economics in undergraduate, postgraduate, and professional courses in Oxford and Rotterdam. His work is published in numerous international scientific journals and presented in prestigious conferences in his field. Apostolos is Editor of International Journal of Integrated Care (IJIC) and Athens Journal of Health (AJH) as well as Associate Editor of BMC-Health Services Research (BMC-HSR). He also acts as a reviewer in several journals and leads the Health Economics in Integrated Care special interest group of the International Foundation for Integrated Care (IFIC). He is also affiliated to Green Templeton College, University of Oxford.

Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
Tsiachristas A. et al, (2017), Journal of Medical Screening
Financial Incentives to Stimulate Integration of Care.
Tsiachristas A., (2016), Int J Integr Care, 16, 8 - 8
Economic impact of Early Intervention in Psychosis services: results from a longitudinal retrospective controlled study in England
Tsiachristas A. et al, (2016), BMJ Open
B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?
Tsiachristas A. and Smith AD., (2016), Alzheimer's and Dementia: Translational Research and Clinical Interventions, 2, 156 - 161
A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC. et al, (2016), Health Technol Assess, 20, 1 - 138
Impact of financial agreements in European chronic care on health care expenditure growth.
Tsiachristas A. et al, (2016), Health Policy (Amsterdam, Netherlands), 120, 420 - 430
Is integrated COPD care cost-effective?
Boland M. et al, (2016), Huisarts en Wetenschap, 59, 343 - 345
Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial.
Boland MR. et al, (2015), NPJ Prim Care Respir Med, 25
Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands.
Tsiachristas A. et al, (2015), Value Health, 18, 977 - 986
Performance Score Extraction from Panel Data for Multi-Criteria Decision Analysis (Mcda) Using a Regression-Based Approach.
Verbeek NA. et al, (2015), Value Health, 18
Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial.
Boland MR. et al, (2015), BMJ Open, 5
Copd Performance Indicators In An Integrated Care Program And Its Impact On Health Outcomes: The Recode Cluster Randomized Trial.
Boland MR. et al, (2015), Value Health, 18
A Triple Aim Framework For The Performance Assessment Of Disease Management Programs.
Verbeek NA. et al, (2015), Value Health, 18
Bridging knowledge to develop an action plan for integrated care for chronic diseases in Greece.
Tsiachristas A. et al, (2015), Int J Integr Care, 15
Does registration of performance indicators improve health outcomes in COPD?
Boland M. et al, (2015), European Respiratory Journal, 46, OA3286 - OA3286
Costs and effects of new professional roles: Evidence from a literature review.
Tsiachristas A. et al, (2015), Health Policy, 119, 1176 - 1187
Finding the royal way to stimulate and evaluate integrated care in Europe
Tsiachristas A., (2015), International Journal of Care Coordination, 18, 48 - 50
Payment and economic evaluation of integrated care.
Tsiachristas A., (2015), Int J Integr Care, 15
Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: Results of cluster randomised trial
Kruis AL. et al, (2015), Nederlands Tijdschrift voor Geneeskunde, 159
Multi-Criteria Decision Analysis for Reimbursing Orphan Drugs: A Dutch Demonstration Study Using the Analytic Hierarchy Process Method.
Trip AM. et al, (2014), Value Health, 17, A541 - A542
Cost-Effectiveness Of Disease Management Programs For Cardiovascular Risk And Copd In The Netherlands.
Tsiachristas A. et al, (2014), Value Health, 17
Cost-Effectiveness of a COPD Disease Management Program in Primary Care: The Recode Cluster Randomized Trial.
Boland MR. et al, (2014), Value Health, 17
Identifying and explaining the variability in development and implementation costs of disease management programs in the Netherlands.
Tsiachristas A. et al, (2014), BMC Health Serv Res, 14
Effectiveness of integrated disease management for primary care chronic obstructive pulmonary disease patients: results of cluster randomised trial.
Kruis AL. et al, (2014), BMJ, 349
The role of disease management programs in the health behavior of chronically ill patients.
Cramm JM. et al, (2014), Patient Educ Couns, 95, 137 - 142
Exploring the variability of patient costs in disease management programs: A hierarchical modelling approach
Tsiachristas A. and Rutten-van Mölken MPMH., (2014), Applied Economics, 46, 940 - 951
Are GOLD ABCD groups better associated with health status and costs than GOLD 1234 grades? A cross-sectional study.
Boland MR. et al, (2014), Prim Care Respir J, 23, 30 - 37
Changes in costs and effects after the implementation of disease management programs in the Netherlands: variability and determinants.
Tsiachristas A. et al, (2014), Cost Eff Resour Alloc, 12
Exploring payment schemes used to promote integrated chronic care in Europe.
Tsiachristas A. et al, (2013), Health Policy, 113, 296 - 304
The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis.
Boland MR. et al, (2013), BMC Pulm Med, 13
Broader economic evaluation of disease management programs using multi-criteria decision analysis.
Tsiachristas A. et al, (2013), Int J Technol Assess Health Care, 29, 301 - 308
RECODE: design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care.
Kruis AL. et al, (2013), BMC Pulm Med, 13
The welfare effects of innovative pharmaceuticals: An international perspective from the Dutch experience
Tsiachristas A. et al, (2013), Applied Economics, 45, 1219 - 1226
The management of cardiovascular disease in the Netherlands: analysis of different programmes.
Cramm JM. et al, (2013), Int J Integr Care, 13
PRS40 Are Disease Management Programs for COPD Cost-Saving?
Boland MR. et al, (2012), Value Health, 15
PHP78 System-Wide Impact of Payment Schemes for Integrated Care of Chronic Diseases in Europe: Evidence from an Empirical Analysis.
Tsiachristas A. et al, (2012), Value Health, 15
Development and validation of a short version of the Assessment of Chronic Illness Care (ACIC) in Dutch disease management programs.
Cramm JM. et al, (2011), Health Qual Life Outcomes, 9
Towards integrated care for chronic conditions: Dutch policy developments to overcome the (financial) barriers.
Tsiachristas A. et al, (2011), Health Policy, 101, 122 - 132
Potential barriers to the application of multi-factor portfolio analysis in public hospitals: evidence from a pilot study in the Netherlands.
Pavlova M. et al, (2009), Int J Health Plann Manage, 24, 43 - 68
Performing economic evaluation of integrated care: highway to hell or stairway to heaven?
Tsiachristas A. et al, International Journal of Integrated Care

Key publications

Performing economic evaluation of integrated care: highway to hell or stairway to heaven?
Tsiachristas A. et al, International Journal of Integrated Care
Broader economic evaluation of disease management programs using multi-criteria decision analysis.
Tsiachristas A. et al, (2013), Int J Technol Assess Health Care, 29, 301 - 308

Recent Publications

Cost-effectiveness of strategies to increase cervical screening uptake at first invitation (STRATEGIC)
Tsiachristas A. et al, (2017), Journal of Medical Screening
Financial Incentives to Stimulate Integration of Care.
Tsiachristas A., (2016), Int J Integr Care, 16, 8 - 8
Economic impact of Early Intervention in Psychosis services: results from a longitudinal retrospective controlled study in England
Tsiachristas A. et al, (2016), BMJ Open
B-vitamins are potentially a cost-effective population health strategy to tackle dementia: Too good to be true?
Tsiachristas A. and Smith AD., (2016), Alzheimer's and Dementia: Translational Research and Clinical Interventions, 2, 156 - 161
A cluster randomised trial of strategies to increase cervical screening uptake at first invitation (STRATEGIC).
Kitchener HC. et al, (2016), Health Technol Assess, 20, 1 - 138